Skip to main content
Livermore
Livermore
ZHEN

Ellevest, Inc.

SEC CIK
0001644128
Latest filing
Aug 10, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by Ellevest, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
29,996
Value
$480.4K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of TAK by Ellevest, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202629,996$480.4K0.1%+585+2.0%AddedHolders
Q1 202629,411$544.7K0.1%−4,330−12.8%ReducedHolders
Q4 202533,741$526.0K0.1%−14,832−30.5%ReducedHolders
Q3 202548,573$711.1K0.1%+5,624+13.1%AddedHolders
Q2 202542,949$664.0K0.1%+14,612+51.6%AddedHolders
Q1 202528,337$421.4K<0.1%−12,042−29.8%ReducedHolders
Q4 202440,379$534.6K<0.1%−38,549−48.8%ReducedHolders
Q3 202478,928$1.12M0.1%+22,845+40.7%AddedHolders
Q2 202456,083$725.7K<0.1%−22,156−28.3%ReducedHolders
Q1 202478,239$1.09M0.1%+14,814+23.4%AddedHolders
Q4 202363,425$905.1K0.1%−13,156−17.2%ReducedHolders
Q3 202376,581$1.18M0.1%+24,608+47.3%AddedHolders
Q2 202351,973$816.5K0.1%+9,619+22.7%AddedHolders
Q1 202342,354$698.0K0.1%+13,451+46.5%AddedHolders
Q4 202228,903$450.9K<0.1%+21,050+268.1%AddedHolders
Q3 20227,853$102.0K<0.1%−5,868−42.8%ReducedHolders
Q2 202213,721$193.0K<0.1%−17,264−55.7%ReducedHolders
Q1 202230,985$444.0K<0.1%+6,153+24.8%AddedHolders
Q4 202124,832$338.0K<0.1%+2,008+8.8%AddedHolders
Q3 202122,824$374.0K<0.1%+7,350+47.5%AddedHolders
Q2 202115,474$260.0K<0.1%+292+1.9%AddedHolders
Q1 202115,182$277.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.